The DOI matches its Crossref record; 198 of the 198 references it cites were found in a registry or an index.
Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
Open accessAbstract
Chemotherapy-induced neuropathy is a common, dose-dependent adverse effect of several antineoplastics. It can lead to detrimental dose reductions and discontinuation of treatment, and severely affects the quality of life of cancer survivors. Clinically, chemotherapy-induced peripheral neuropathy presents as deficits in sensory, motor, and autonomic function which develop in a glove and stocking distribution due to preferential effects on longer axons. The pathophysiological processes are multi-factorial and involve oxidative stress, apoptotic mechanisms, altered calcium homeostasis, axon degeneration and membrane remodeling as well as immune processes and neuroinflammation. This review focusses on the commonly used antineoplastic substances oxaliplatin, cisplatin, vincristine, docetaxel, and paclitaxel which interfere with the cancer cell cycle-leading to cell death and tumor degradation-and cause severe acute and chronic peripheral neuropathies. We discuss drug mechanism of action and pharmacokinetic disposition relevant to the development of peripheral neuropathy, the epidemiology and clinical presentation of chemotherapy-induced neuropathy, emerging insight into genetic susceptibilities as well as current understanding of the pathophysiology and treatment approaches.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Cisplatin in cancer therapy: Molecular mechanisms of action
Dasari, S., & Bernard Tchounwou, P. (2014) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2014.07.025 · Cited by 5,537
Metals, Toxicity and Oxidative Stress
Valko, M., Morris, H., & Cronin, M. (2005) · Current Medicinal Chemistry · doi:10.2174/0929867053764635 · Cited by 5,018
Immunological aspects of cancer chemotherapy
Zitvogel, L., Apetoh, L., Ghiringhelli, F., & Kroemer, G. (2008) · Nature Reviews Immunology · doi:10.1038/nri2216 · Cited by 1,712
Free Radical Mechanisms in Tissue Injury
Slater, T. F. (1988) · Cell Function and Disease · doi:10.1007/978-1-4613-0813-3_18 · Cited by 1,555
Seretny, M., Currie, G. L., Sena, E. S., Ramnarine, S., Grant, R., MacLeod, M. R., Colvin, L. A., & Fallon, M. (2014) · Pain · doi:10.1016/j.pain.2014.09.020 · Cited by 1,555
Free-radical mechanisms in tissue injury
Slater, T. F. (1984) · Biochemical Journal · doi:10.1042/bj2220001 · Cited by 1,538
Immunogenic death of colon cancer cells treated with oxaliplatin
Tesniere, A., Schlemmer, F., Boige, V, Kepp, O., Martins, I., Ghiringhelli, F., Aymeric, L., Michaud, M., Apetoh, L., Barault, L., et al. (2010) · Oncogene · doi:10.1038/onc.2009.356 · Cited by 1,173
Smith, E. M. L., Pang, H., Cirrincione, C., Fleishman, S., Paskett, E. D., Ahles, T., Bressler, L. R., Fadul, C. E., Knox, C., Le-Lindqwister, N., et al. (2013) · JAMA · doi:10.1001/jama.2013.2813 · Cited by 1,014
Chemotherapy-induced peripheral neuropathy
Quasthoff, S., & Hartung, H. P. (2002) · Journal of Neurology · doi:10.1007/pl00007853 · Cited by 966
Bulua, A. C., Simon, A., Maddipati, R., Pelletier, M., Park, H., Kim, K.-Y., Sack, M. N., Kastner, D. L., & Siegel, R. M. (2011) · Journal of Experimental Medicine · doi:10.1084/jem.20102049 · Cited by 860 · cited 1×
“Furthermore, ROS can cause the activation of apoptotic pathways (Cashman and Hoke, 2015) and increase production of pro-inflammatory mediators (Bulua et al., 2011).”
BackgroundRaghavendra, V., Tanga, F., & DeLeo, J. A. (2003) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.103.052407 · Cited by 797
Chemotherapy‐induced peripheral neurotoxicity: A critical analysis
Park, S. B., Goldstein, D., Krishnan, A. V., Lin, C. S., Friedlander, M. L., Cassidy, J., Koltzenburg, M., & Kiernan, M. C. (2013) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21204 · Cited by 741
The Intricate Role of CXCR4 in Cancer
(2014) · Advances in Cancer Research · doi:10.1016/b978-0-12-411638-2.00002-1 · Cited by 672
Inhibition of transcription by platinum antitumor compounds
Todd, R. C., & Lippard, S. J. (2009) · Metallomics · doi:10.1039/b907567d · Cited by 539
Flatters, S. J. L., & Bennett, G. J. (2006) · Pain · doi:10.1016/j.pain.2006.01.037 · Cited by 535
Glutathione metabolism as a determinant of therapeutic efficacy: a review.
Arrick, B. A., & Nathan, C. (1984) · PubMed · Cited by 506
Grisold, W., Cavaletti, G., & Windebank, A. J. (2012) · Neuro-Oncology · doi:10.1093/neuonc/nos203 · Cited by 486
Kemp, G., Rose, P., Lurain, J., Berman, M., Manetta, A., Roullet, B., Homesley, H., Belpomme, D., & Glick, J. (1996) · Journal of Clinical Oncology · doi:10.1200/jco.1996.14.7.2101 · Cited by 463
Oxidative stress and nerve damage: Role in chemotherapy induced peripheral neuropathy
Areti, A., Yerra, V. G., Naidu, V., & Kumar, A. (2014) · Redox Biology · doi:10.1016/j.redox.2014.01.006 · Cited by 456
Oxaliplatin: A Review in the Era of Molecularly Targeted Therapy
Alcindor, T., & Beauger, N. (2011) · Current Oncology · doi:10.3747/co.v18i1.708 · Cited by 432
Chemotherapy-induced peripheral neuropathy: What do we know about mechanisms?
Carozzi, V. A., Canta, A., & Chiorazzi, A. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2014.10.014 · Cited by 431
Cascinu, S., Catalano, V., Cordella, L., Labianca, R., Giordani, P., Baldelli, A. M., Beretta, G. D., Ubiali, E., & Catalano, G. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.07.061 · Cited by 421
Sodium Channels and Mechanisms of Neuropathic Pain
Devor, M. (2006) · The Journal of Pain · doi:10.1016/j.jpain.2005.09.006 · Cited by 401
Cisplatin neuropathy. Clinical, electrophysiologic, morphologic, and toxicologic studies
Thompson, S. W., Davis, L. E., Kornfeld, M., Hilgers, R. D., & Standefer, J. C. (1984) · Cancer · doi:10.1002/1097-0142(19841001)54:7<1269::aid-cncr2820540707>3.0.co;2-9 · Cited by 394
Peripheral sensory neuropathy and cisplatin chemotherapy
Roelofs, R. I., Hrushesky, W., Rogin, J., & Rosenberg, L. (1984) · Neurology · doi:10.1212/wnl.34.7.934 · Cited by 370
Dougherty, P. M., Cata, J. P., Cordella, J. V., Burton, A., & Weng, H.-R. (2004) · Pain · doi:10.1016/j.pain.2004.01.021 · Cited by 369
Descoeur, J., Pereira, V., Pizzoccaro, A., Francois, A., Ling, B., Maffre, V., Couette, B., Busserolles, J., Courteix, C., Noel, J., et al. (2011) · EMBO Molecular Medicine · doi:10.1002/emmm.201100134 · Cited by 368
Zhang, H., Li, Y., de Carvalho-Barbosa, M., Kavelaars, A., Heijnen, C. J., Albrecht, P. J., & Dougherty, P. M. (2016) · The Journal of Pain · doi:10.1016/j.jpain.2016.02.011 · Cited by 365
Rao, R. D., Michalak, J. C., Sloan, J. A., Loprinzi, C. L., Soori, G. S., Nikcevich, D. A., Warner, D. O., Novotny, P., Kutteh, L. A., Wong, G. Y., et al. (2007) · Cancer · doi:10.1002/cncr.23008 · Cited by 360
Gregg, R. W., Molepo, J. M., Monpetit, V. J., Mikael, N. Z., Redmond, D., Gadia, M., & Stewart, D. J. (1992) · Journal of Clinical Oncology · doi:10.1200/jco.1992.10.5.795 · Cited by 358
Prevention of Oxaliplatin-Related Neurotoxicity by Calcium and Magnesium Infusions
Gamelin, L., Boisdron‐Celle, M., Delva, R., Guerin‐Meyer, V., Ifrah, N., Morel, A., & Gamelin, E. C. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-03-0666 · Cited by 346
Oxidation of Methionine Residues of Proteins: Biological Consequences
Stadtman, E. R., Moskovitz, J., & Levine, R. L. (2003) · Antioxidants & Redox Signaling · doi:10.1089/152308603770310239 · Cited by 344
Oxaliplatin elicits mechanical and cold allodynia in rodents via TRPA1 receptor stimulation
Nassini, R., Gees, M., Harrison, S., De Siena, G., Materazzi, S., Moretto, N., Failli, P., Preti, D., Marchetti, N., Cavazzini, A., et al. (2011) · Pain · doi:10.1016/j.pain.2011.02.051 · Cited by 324
Holzer, A. K., Manorek, G. H., & Howell, S. B. (2006) · Molecular Pharmacology · doi:10.1124/mol.106.022624 · Cited by 322
Taxol produces a predominantly sensory neuropathy
Lipton, R. B., Apfel, S. C., Dutcher, J. P., Rosenberg, R., Kaplan, J., Berger, A., Einzig, A. I., Wiernik, P., & Schaumburg, H. H. (1989) · Neurology · doi:10.1212/wnl.39.3.368 · Cited by 318
Depression, Anxiety, and Quality of Life in Patients with Epithelial Ovarian Cancer
Bodurka-Bevers, D., Basen-Engquist, K., Carmack, C. L., Fitzgerald, M. A., Wolf, J. K., de Moor, C., & Gershenson, D. M. (2000) · Gynecologic Oncology · doi:10.1006/gyno.2000.5908 · Cited by 311
Ledeboer, A., Jekich, B. M., Sloane, E. M., Mahoney, J. H., Langer, S. J., Milligan, E. D., Martin, D., Maier, S. F., Johnson, K. W., Leinwand, L. A., et al. (2007) · Brain, Behavior, and Immunity · doi:10.1016/j.bbi.2006.10.012 · Cited by 308
Neuroprotective Effect of Vitamin E Supplementation in Patients Treated With Cisplatin Chemotherapy
Pace, A., Savarese, A., Picardo, M., Maresca, V., Pacetti, U., Del Monte, G., Biroccio, A., Leonetti, C., Jandolo, B., Cognetti, F., et al. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.05.139 · Cited by 307
Bécouarn, Y., Ychou, M., Ducreux, M., Borel, C., Bertheault-Cvitkovic, F., Seitz, J. F., Nasca, S., Nguyen, T. D., Paillot, B., Raoul, J. L., et al. (1998) · Journal of Clinical Oncology · doi:10.1200/jco.1998.16.8.2739 · Cited by 301
The chemotherapeutic oxaliplatin alters voltage-gated Na+ channel kinetics on rat sensory neurons
Adelsberger, H., Quasthoff, S., Grosskreutz, J., Lepier, A., Eckel, F., & Lersch, C. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00667-1 · Cited by 290
Peters, C. M., Jimenez-Andrade, J. M., Jonas, B. M., Sevcik, M. A., Koewler, N. J., Ghilardi, J. R., Wong, G. Y., & Mantyh, P. W. (2007) · Experimental Neurology · doi:10.1016/j.expneurol.2006.07.022 · Cited by 288
Natural History of Paclitaxel-Associated Acute Pain Syndrome: Prospective Cohort Study NCCTG N08C1
Loprinzi, C. L., Reeves, B. N., Dakhil, S. R., Sloan, J. A., Wolf, S. L., Burger, K. N., Kamal, A., Le-Lindqwister, N. A., Soori, G. S., Jaslowski, A. J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.33.0308 · Cited by 281
Diouf, B., Crews, K. R., Lew, G., Pei, D., Cheng, C., Bao, J., Zheng, J. J., Yang, W., Fan, Y., Wheeler, H. E., et al. (2015) · JAMA · doi:10.1001/jama.2015.0894 · Cited by 278
Pathobiology of cancer chemotherapy-induced peripheral neuropathy (CIPN)
Han, Y., & Smith, M. T. (2013) · Frontiers in Pharmacology · doi:10.3389/fphar.2013.00156 · Cited by 273
Zheng, H., Xiao, W. H., & Bennett, G. J. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.08.016 · Cited by 272
Winer, E. P., Berry, D. A., Woolf, S., Duggan, D., Kornblith, A., Harris, L. N., Michaelson, R. A., Kirshner, J. A., Fleming, G. F., Perry, M. C., et al. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.08.048 · Cited by 270
Oxaliplatin-Associated Neuropathy: A Review
Cersosimo, R. J. (2005) · Annals of Pharmacotherapy · doi:10.1345/aph.1e319 · Cited by 268
The neuromyopathy of vincristine in man
Bradley, W. G., Lassman, L. P., Pearce, G. W., & Walton, J. N. (1970) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(70)90013-4 · Cited by 261
Song, I.-S., Savaraj, N., Siddik, Z. H., Liu, P., Wei, Y., Wu, C. J., & Kuo, M. T. (2004) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.1543.3.12 · Cited by 259
Barton, D. L., Wos, E. J., Qin, R., Mattar, B. I., Green, N. B., Lanier, K. S., Bearden, J. D., Kugler, J. W., Hoff, K. L., Reddy, P. S., et al. (2011) · Supportive Care in Cancer · doi:10.1007/s00520-010-0911-0 · Cited by 255
Copper transporters regulate the cellular pharmacology and sensitivity to Pt drugs
Safaei, R., & Howell, S. B. (2005) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2004.09.007 · Cited by 254
Makker, P. G. S., Duffy, S. S., Lees, J. G., Perera, C. J., Tonkin, R. S., Butovsky, O., Park, S. B., Goldstein, D., & Moalem-Taylor, G. (2017) · PLOS ONE · doi:10.1371/journal.pone.0170814 · Cited by 254
Peripheral nerve damage associated with administration of taxanes in patients with cancer
Argyriou, A. A., Koltzenburg, M., Polychronopoulos, P., Papapetropoulos, S., & Kalofonos, H. P. (2008) · Critical Reviews in Oncology/Hematology · doi:10.1016/j.critrevonc.2008.01.008 · Cited by 240
Sangeetha, P. (1990) · Free Radical Biology and Medicine · doi:10.1016/0891-5849(90)90139-a · Cited by 235
Strumberg, D., Brügge, S., Korn, M. W., Koeppen, S., Ranft, J., Scheiber, G., Reiners, C., Möckel, C., Seeber, S., & Scheulen, M. E. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf058 · Cited by 232
Hammack, J. E., Michalak, J. C., Loprinzi, C. L., Sloan, J. A., Novotny, P. J., Soori, G. S., Tirona, M. T., Rowland, K. M., Stella, P. J., & Johnson, J. A. (2002) · Pain · doi:10.1016/s0304-3959(02)00047-7 · Cited by 231
Alessandri-Haber, N., Dina, O. A., Joseph, E. K., Reichling, D. B., & Levine, J. D. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.4497-07.2008 · Cited by 226
Materazzi, S., Fusi, C., Benemei, S., Pedretti, P., Patacchini, R., Nilius, B., Prenen, J., Creminon, C., Geppetti, P., & Nassini, R. (2012) · Pflügers Archiv - European Journal of Physiology · doi:10.1007/s00424-011-1071-x · Cited by 224
Argyriou, A. A., Cavaletti, G., Briani, C., Velasco, R., Bruna, J., Campagnolo, M., Alberti, P., Bergamo, F., Cortinovis, D., Cazzaniga, M., et al. (2013) · Cancer · doi:10.1002/cncr.27732 · Cited by 221
The contribution of satellite glial cells to chemotherapy‐induced neuropathic pain
Warwick, R. A., & Hanani, M. (2013) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00219.x · Cited by 221
Discovering cytokines as targets for chemotherapy-induced painful peripheral neuropathy
Wang, X.-M., Lehky, T. J., Brell, J. M., & Dorsey, S. G. (2012) · Cytokine · doi:10.1016/j.cyto.2012.03.027 · Cited by 220
Broyl, A., Corthals, S. L., Jongen, J. L., van der Holt, B., Kuiper, R., de Knegt, Y., van Duin, M., el Jarari, L., Bertsch, U., Lokhorst, H. M., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70206-0 · Cited by 219
Oxaliplatin‐induced neurotoxicity and the development of neuropathy
Krishnan, A. V., Goldstein, D., Friedlander, M., & Kiernan, M. C. (2005) · Muscle & Nerve · doi:10.1002/mus.20340 · Cited by 216
Mitochondrial Dysfunction in Chemotherapy-Induced Peripheral Neuropathy (CIPN)
Canta, A., Pozzi, E., & Carozzi, V. (2015) · Toxics · doi:10.3390/toxics3020198 · Cited by 215
Cisplatin combination chemotherapy induces a fall in plasma antioxidants of cancer patients
Weijl, N. I., Hopman, G. D., Wipkink-Bakker, A., Lentjes, E. G. W. M., Berger, H. M., Cleton, F. J., & Osanto, S. (1998) · Annals of Oncology · doi:10.1023/a:1008407014084 · Cited by 214
Hershman, D. L., Unger, J. M., Crew, K. D., Minasian, L. M., Awad, D., Moinpour, C. M., Hansen, L., Lew, D. L., Greenlee, H., Fehrenbacher, L., et al. (2013) · Journal of Clinical Oncology · doi:10.1200/jco.2012.44.8738 · Cited by 214
Zhang, H., Yoon, S.-Y., Zhang, H., & Dougherty, P. M. (2012) · The Journal of Pain · doi:10.1016/j.jpain.2011.12.002 · Cited by 213
Amitriptyline in the Treatment of Chemotherapy-Induced Neuropathic Symptoms
Kautio, A.-L., Haanpää, M., Saarto, T., & Kalso, E. (2008) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2007.02.043 · Cited by 213
Lecomte, T., Landi, B., Beaune, P., Laurent-Puig, P., & Loriot, M.-A. (2006) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-2076 · Cited by 211
DNA strand breaks and apoptosis induced by oxaliplatin in cancer cells
Faivre, S., Chan, D., Salinas, R., Woynarowska, B., & Woynarowski, J. M. (2003) · Biochemical Pharmacology · doi:10.1016/s0006-2952(03)00260-0 · Cited by 211
Wang, W.-S., Lin, J.-K., Lin, T.-C., Chen, W.-S., Jiang, J.-K., Wang, H.-S., Chiou, T.-J., Liu, J.-H., Yen, C.-C., & Chen, P.-M. (2007) · The Oncologist · doi:10.1634/theoncologist.12-3-312 · Cited by 210
Vitamin E for prophylaxis against chemotherapy-induced neuropathy: A randomized controlled trial
Argyriou, A. A., Chroni, E., Koutras, A., Ellul, J., Papapetropoulos, S., Katsoulas, G., Iconomou, G., & Kalofonos, H. P. (2005) · Neurology · doi:10.1212/01.wnl.0000148609.35718.7d · Cited by 209
Zhang, L., Dermawan, K., Jin, M., Liu, R., Zheng, H., Xu, L., Zhang, Y., Cai, Y., Chu, Y., & Xiong, S. (2008) · Clinical Immunology · doi:10.1016/j.clim.2008.07.013 · Cited by 209
Sittl, R., Lampert, A., Huth, T., Schuy, E. T., Link, A. S., Fleckenstein, J., Alzheimer, C., Grafe, P., & Carr, R. W. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118058109 · Cited by 209
Kidd, J. F., Pilkington, M. F., Schell, M. J., Fogarty, K. E., Skepper, J. N., Taylor, C. W., & Thorn, P. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m106802200 · Cited by 205
Baldwin, R. M., Owzar, K., Zembutsu, H., Chhibber, A., Kubo, M., Jiang, C., Watson, D., Eclov, R. J., Mefford, J., McLeod, H. L., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1590 · Cited by 204
Krukowski, K., Eijkelkamp, N., Laumet, G., Hack, C. E., Li, Y., Dougherty, P. M., Heijnen, C. J., & Kavelaars, A. (2016) · The Journal of Neuroscience · doi:10.1523/jneurosci.3708-15.2016 · Cited by 203
Boyette-Davis, J., Xin, W., Zhang, H., & Dougherty, P. M. (2011) · Pain · doi:10.1016/j.pain.2010.10.030 · Cited by 202
Prospective study of paclitaxel-induced peripheral neuropathy with quantitative sensory testing
Forsyth, P. A., Balmaceda, C., Peterson, K., Seidman, A. D., Brasher, P., & Deangelis, L. M. (1997) · Journal of Neuro-Oncology · doi:10.1023/a:1005805907311 · Cited by 199
Mechanisms of distal axonal degeneration in peripheral neuropathies
Cashman, C. R., & Höke, A. (2015) · Neuroscience Letters · doi:10.1016/j.neulet.2015.01.048 · Cited by 199
Lavoie Smith, E. M., Li, L., Chiang, C., Thomas, K., Hutchinson, R. J., Wells, E. M., Ho, R. H., Skiles, J., Chakraborty, A., Bridges, C. M., et al. (2015) · Journal of the Peripheral Nervous System · doi:10.1111/jns.12114 · Cited by 198
Rao, R. D., Flynn, P. J., Sloan, J. A., Wong, G. Y., Novotny, P., Johnson, D. B., Gross, H. M., Renno, S. I., Nashawaty, M., & Loprinzi, C. L. (2008) · Cancer · doi:10.1002/cncr.23482 · Cited by 193
Ta, L. E., Bieber, A. J., Carlton, S. M., Loprinzi, C. L., Low, P. A., & Windebank, A. J. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-15 · Cited by 193
Vitamin E neuroprotection for cisplatin neuropathy: A randomized, placebo-controlled trial
Pace, A., Giannarelli, D., Galiè, E., Savarese, A., Carpano, S., Della Giulia, M., Pozzi, A., Silvani, A., Gaviani, P., Scaioli, V., et al. (2010) · Neurology · doi:10.1212/wnl.0b013e3181d5279e · Cited by 191
Khrunin, A. V., Moisseev, A., Gorbunova, V, & Limborska, S. (2010) · The Pharmacogenomics Journal · doi:10.1038/tpj.2009.45 · Cited by 190
Topp, K. S., Tanner, K. D., & Levine, J. D. (2000) · The Journal of Comparative Neurology · doi:10.1002/1096-9861(20000904)424:4<563::aid-cne1>3.0.co;2-u · Cited by 189
Duggett, N. A., Griffiths, L. A., McKenna, O. E., de Santis, V., Yongsanguanchai, N., Mokori, E. B., & Flatters, S. J. L. (2016) · Neuroscience · doi:10.1016/j.neuroscience.2016.06.050 · Cited by 189
Cavaletti, G., Tredici, G., Braga, M., & Tazzari, S. (1995) · Experimental Neurology · doi:10.1006/exnr.1995.1008 · Cited by 185
Dysregulation of Cellular Calcium Homeostasis in Chemotherapy-Evoked Painful Peripheral Neuropathy
Siau, C., & Bennett, G. J. (2006) · Anesthesia & Analgesia · doi:10.1213/01.ane.0000204318.35194.ed · Cited by 183
Smyth, J. F., Bowman, A., Perren, T., Wilkinson, P., Prescott, R. J., Quinn, K. J., & Tedeschi, M. (1997) · Annals of Oncology · doi:10.1023/a:1008211226339 · Cited by 178
Monocytes expressing CX3CR1 orchestrate the development of vincristine-induced pain
Old, E. A., Nadkarni, S., Grist, J., Gentry, C., Bevan, S., Kim, K.-W., Mogg, A. J., Perretti, M., & Malcangio, M. (2014) · Journal of Clinical Investigation · doi:10.1172/jci71389 · Cited by 177
Immune-mediated processes implicated in chemotherapy-induced peripheral neuropathy
Lees, J. G., Makker, P. G. S., Tonkin, R. S., Abdulla, M., Park, S. B., Goldstein, D., & Moalem-Taylor, G. (2017) · European Journal of Cancer · doi:10.1016/j.ejca.2016.12.006 · Cited by 176
Oxaliplatin-induced neurotoxicity is dependent on the organic cation transporter OCT2
Sprowl, J. A., Ciarimboli, G., Lancaster, C. S., Giovinazzo, H., Gibson, A. A., Du, G., Janke, L. J., Cavaletti, G., Shields, A. F., & Sparreboom, A. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1305321110 · Cited by 175
Toxic neuropathy in patients with pre-existing neuropathy
Chaudhry, V., Chaudhry, M., Crawford, T. O., Simmons-O’Brien, E., & Griffin, J. W. (2003) · Neurology · doi:10.1212/01.wnl.0000043691.53710.53 · Cited by 173
Deuis, J. R., Zimmermann, K., Romanovsky, A. A., Possani, L. D., Cabot, P. J., Lewis, R. J., & Vetter, I. (2013) · Pain · doi:10.1016/j.pain.2013.05.032 · Cited by 171
Self-citationGhoreishi, Z., Esfahani, A., Djazayeri, A., Djalali, M., Golestan, B., Ayromlou, H., Hashemzade, S., Asghari Jafarabadi, M., Montazeri, V., Keshavarz, S. A., et al. (2012) · BMC Cancer · doi:10.1186/1471-2407-12-355 · Cited by 171
Bernhardson, B.-M., Tishelman, C., & Rutqvist, L. E. (2007) · Journal of Pain and Symptom Management · doi:10.1016/j.jpainsymman.2006.12.010 · Cited by 169
Zhang, H., & Dougherty, P. M. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000176 · Cited by 169
Glial role in oxaliplatin-induced neuropathic pain
Di Cesare Mannelli, L., Pacini, A., Micheli, L., Tani, A., Zanardelli, M., & Ghelardini, C. (2014) · Experimental Neurology · doi:10.1016/j.expneurol.2014.06.016 · Cited by 168
Doyle, T., Chen, Z., Muscoli, C., Bryant, L., Esposito, E., Cuzzocrea, S., Dagostino, C., Ryerse, J., Rausaria, S., Kamadulski, A., et al. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6343-11.2012 · Cited by 168
Cavaletti, G., Cavalletti, E., Oggioni, N., Sottani, C., Minoia, C., D’Incalci, M., Zucchetti, M., Marmiroli, P., & Tredici, G. (2000) · PubMed · Cited by 167
Vincristine-induced peripheral neuropathy in pediatric cancer patients.
Mora, E., Smith, E., Donohoe, C., & Hertz, D. L. (2016) · PubMed · Cited by 167
Robinson, C., Zhang, H., & Dougherty, P. M. (2014) · Neuroscience · doi:10.1016/j.neuroscience.2014.05.051 · Cited by 164
Cavaletti, G., Tredici, G., Marmiroli, P., Petruccioli, M. G., Barajon, I., & Fabbrica, D. (1992) · Acta Neuropathologica · doi:10.1007/bf00227662 · Cited by 164
Mironov, S. L., Ivannikov, M. V., & Johansson, M. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m409819200 · Cited by 164
Taxol Neuropathy: Electrodiagnostic and Sural Nerve Biopsy Findings
Sahenk, Z. (1994) · Archives of Neurology · doi:10.1001/archneur.1994.00540190110024 · Cited by 163
Peripheral neuropathy in survivors of childhood acute lymphoblastic leukemia
Ramchandren, S., Leonard, M., Mody, R. J., Donohue, J. E., Moyer, J., Hutchinson, R., & Gurney, J. G. (2009) · Journal of the Peripheral Nervous System · doi:10.1111/j.1529-8027.2009.00230.x · Cited by 163
Reeves, B. N., Dakhil, S. R., Sloan, J. A., Wolf, S. L., Burger, K. N., Kamal, A., Le‐Lindqwister, N. A., Soori, G. S., Jaslowski, A. J., Kelaghan, J., et al. (2012) · Cancer · doi:10.1002/cncr.27489 · Cited by 161
Quantitative Sensory Findings in Patients With Bortezomib-Induced Pain
Cata, J. P., Weng, H.-R., Burton, A. W., Villareal, H., Giralt, S., & Dougherty, P. M. (2007) · The Journal of Pain · doi:10.1016/j.jpain.2006.09.014 · Cited by 160
Tanabe, Y., Hashimoto, K., Shimizu, C., Hirakawa, A., Harano, K., Yunokawa, M., Yonemori, K., Katsumata, N., Tamura, K., Ando, M., et al. (2013) · International Journal of Clinical Oncology · doi:10.1007/s10147-011-0352-x · Cited by 160
Gauchan, P., Andoh, T., Kato, A., & Kuraishi, Y. (2009) · Neuroscience Letters · doi:10.1016/j.neulet.2009.04.029 · Cited by 160
Janes, K., Little, J. W., Li, C., Bryant, L., Chen, C., Chen, Z., Kamocki, K., Doyle, T., Snider, A., Esposito, E., et al. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.569574 · Cited by 159
Boehmerle, W., Huehnchen, P., Peruzzaro, S., Balkaya, M., & Endres, M. (2014) · Scientific Reports · doi:10.1038/srep06370 · Cited by 159
Nociceptive neurons regulate innate and adaptive immunity and neuropathic pain through MyD88 adapter
Liu, X.-J., Zhang, Y., Liu, T., Xu, Z.-Z., Park, C.-K., Berta, T., Jiang, D., & Ji, R.-R. (2014) · Cell Research · doi:10.1038/cr.2014.106 · Cited by 158
Cascinu, S., Cordella, L., Ferro, E. D., Fronzoni, M., & Catalano, G. (1995) · Journal of Clinical Oncology · doi:10.1200/jco.1995.13.1.26 · Cited by 158
Cavaletti, G., Cavalletti, E., Oggioni, N., Sottani, C., Minoia, C., D’Incalci, M., Zucchetti, M., Marmiroli, P., & Tredici, G. (2001) · Journal of the Peripheral Nervous System · doi:10.1046/j.1529-8027.2001.01008-5.x · Cited by 157
Long term effects of vincristine on the peripheral nervous system
Postma, T. J., Benard, B. A., Huijgens, P. C., Ossenkoppele, G. J., & Heimans, J. J. (1993) · Journal of Neuro-Oncology · doi:10.1007/bf01050259 · Cited by 154
Boehmerle, W., Splittgerber, U., Lazarus, M. B., McKenzie, K. M., Johnston, D. G., Austin, D. J., & Ehrlich, B. E. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607240103 · Cited by 153
Fouladi, M., Chintagumpala, M., Ashley, D. M., Kellie, S. J., Gururangan, S., Hassall, T., Gronewold, L., Stewart, C. F., Wallace, D., Broniscer, A., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.3974 · Cited by 149
Reduction of paclitaxel-induced peripheral neuropathy with glutamine.
Vahdat, L. T., Papadopoulos, K. P., Lange, D., Leuin, S. C., Kaufman, E. A., Donovan, D., Frederick, D., Bagiella, E., Tiersten, A., NICHOLS, G. L., et al. (2001) · PubMed · Cited by 149
Management of oxaliplatin-induced peripheral neuropathy.
Saif, M. W., & Reardon, J. (2005) · PubMed Central · Cited by 148
Persistent chemoneuropathy in patients receiving the plant alkaloids paclitaxel and vincristine
Boyette-Davis, J. A., Cata, J. P., Driver, L. C., Novy, D. M., Bruel, B. M., Mooring, D. L., Wendelschafer-Crabb, G., Kennedy, W. R., & Dougherty, P. M. (2013) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-012-2047-z · Cited by 148
Boyette-Davis, J. A., & Dougherty, P. M. (2011) · Experimental Neurology · doi:10.1016/j.expneurol.2011.02.019 · Cited by 143
Janes, K., Wahlman, C., Little, J. W., Doyle, T. M., Tosh, D. K., Jacobson, K. A., & Salvemini, D. (2014) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2014.08.010 · Cited by 142
Gregory, R. K., & Smith, I. E. (2000) · British Journal of Cancer · doi:10.1054/bjoc.2000.1203 · Cited by 141
McDonald, E. S., & Windebank, A. J. (2002) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0468 · Cited by 135
Terminal arbor degeneration - a novel lesion produced by the antineoplastic agent paclitaxel
Bennett, G. J., Liu, G. K., Xiao, W. H., Jin, H. W., & Siau, C. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07652.x · Cited by 134
Liu, C., Lü, N., Cui, Y., Yang, T., Zhao, Z., Xin, W., & Liu, X. (2010) · Molecular Pain · doi:10.1186/1744-8069-6-76 · Cited by 125
Cavaletti, G., Cavalletti, E., Montaguti, P., Oggioni, N., Negri, O. D., & Tredici, G. (1997) · PubMed · Cited by 124
Yang, I. H., Siddique, R., Hosmane, S., Thakor, N. V., & Höke, A. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.04.017 · Cited by 124
Chemotherapy-induced peripheral neurotoxicity in the era of pharmacogenomics
Cavaletti, G., Alberti, P., & Marmiroli, P. (2011) · The Lancet Oncology · doi:10.1016/s1470-2045(11)70131-0 · Cited by 123
Argyriou, A. A., Cavaletti, G., Antonacopoulou, A. G., Genazzani, A. A., Briani, C., Bruna, J., Terrazzino, S., Velasco, R., Alberti, P., Campagnolo, M., et al. (2013) · Cancer · doi:10.1002/cncr.28234 · Cited by 115
Maestri, A., Ceratti, A. D. P., Cundari, S., Zanna, C., Cortesi, E., & Crinò, L. (2005) · Tumori Journal · doi:10.1177/030089160509100206 · Cited by 113
Burgos, E., Gómez‐Nicola, D., Pascual, D., Martín, M. I., Nieto‐Sampedro, M., & Goicoechea, C. (2012) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.02.008 · Cited by 113
Janes, K., Esposito, E., Doyle, T. M., Cuzzocrea, S., Tosh, D. K., Jacobson, K. A., & Salvemini, D. (2014) · Pain · doi:10.1016/j.pain.2014.09.016 · Cited by 112
Lin, P., Lee, M.-Y., Wang, W.-S., Yen, C., Chao, T., Hsiao, L., Yang, M., Chen, P., Lin, K., & Chiou, T.-J. (2006) · Supportive Care in Cancer · doi:10.1007/s00520-006-0018-9 · Cited by 112
Cisplatin neuropathy: clinical course and neurophysiological findings
LoMonaco, M., Milone, M., Batocchi, A. P., Padua, L., Restuccia, D., & Tonali, P. A. (1992) · Journal of Neurology · doi:10.1007/bf00839140 · Cited by 109
Role of MAPKs in platinum-induced neuronal apoptosis
Scuteri, A., Galimberti, A., Maggioni, D., Ravasi, M., Pasini, S., Nicolini, G., Bossi, M., Miloso, M., Cavaletti, G., & Tredici, G. (2009) · NeuroToxicology · doi:10.1016/j.neuro.2009.01.003 · Cited by 109
The Paclitaxel Acute Pain Syndrome: Sensitization of Nociceptors as the Putative Mechanism
Loprinzi, C. L., Maddocks‐Christianson, K., Wolf, S. L., Rao, R. D., Dyck, P. J. B., Mantyh, P. W., & Dyck, P. J. B. (2007) · The Cancer Journal · doi:10.1097/ppo.0b013e31815a999b · Cited by 108
Kiguchi, N., Maeda, T., Kobayashi, Y., Kondo, T., Ozaki, M., & Kishioka, S. (2008) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2008.07.008 · Cited by 106
Persistent Mobility Disability After Neurotoxic Chemotherapy
Hile, E. S., Fitzgerald, G. K., & Studenski, S. A. (2010) · Physical Therapy · doi:10.2522/ptj.20090405 · Cited by 106
Guo, Y., Jones, D., Palmer, J. L., Forman, A. D., Dakhil, S. R., Velasco, M. R., Weiss, M., Gilman, P. B., Mills, G. M., Noga, S. J., et al. (2013) · Supportive Care in Cancer · doi:10.1007/s00520-013-2075-1 · Cited by 106
Cisplatin-induced DNA-platination in experimental dorsal root ganglia neuronopathy.
Meijer, C., de Vries, E. G. E., Marmiroli, P., Tredici, G., Frattola, L., & Cavaletti, G. (1999) · PubMed · Cited by 104
Johnson, D. C., Corthals, S. L., Walker, B. A., Ross, F. M., Gregory, W. M., Dickens, N. J., Lokhorst, H. M., Goldschmidt, H., Davies, F. E., Durie, B. G. M., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2010.28.0792 · Cited by 104
Planting, A. S. T., Catimel, G., Mulder, P. H. M. D., de Graeff, A., Höppener, F., Verweij, I., Oster, W., & Vermorken, J. B. (1999) · Annals of Oncology · doi:10.1023/a:1008353505916 · Cited by 99
Park, S. B., Lin, C. S.-Y., Krishnan, A. V., Friedlander, M. L., Lewis, C. R., & Kiernan, M. C. (2010) · Muscle & Nerve · doi:10.1002/mus.21874 · Cited by 98
Gan, P. P., McCarroll, J. A., Po’uha, S. T., Kamath, K., Jordan, M. A., & Kavallaris, M. (2010) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-09-0679 · Cited by 97
Lipid Peroxides in the Polychemotherapy of Cancer Patients
Look, M. P., & Musch, E. (2009) · Chemotherapy · doi:10.1159/000239163 · Cited by 94
Role of pregabalin in treatment of oxaliplatin-induced sensory neuropathy.
Saif, M. W., Syrigos, K., Kaley, K., & Isufi, I. (2010) · PubMed · Cited by 91
Xu, T., Zhang, X., Ouyang, H., Li, Z., Liu, C., Huang, Z., Xu, J., Wei, J., Nie, B., Ma, C., et al. (2017) · Pain · doi:10.1097/j.pain.0000000000000805 · Cited by 90
Spinal CCL2 and microglial activation are involved in paclitaxel-evoked cold hyperalgesia
Pevida, M., Lastra, A., Hidalgo, A., Baamonde, A., & Menéndez, L. (2013) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2013.03.005 · Cited by 87
Li, D., Huang, Z., Ling, Y., Wei, J., Cui, Y., Zhang, X., Zhu, H.-Q., & Xin, W. (2014) · Anesthesiology · doi:10.1097/aln.0000000000000560 · Cited by 85
Predicting Acute and Persistent Neuropathy Associated With Oxaliplatin
Alejandro, L. M., Behrendt, C. E., Chen, K., Openshaw, H., & Shibata, S. (2012) · American Journal of Clinical Oncology · doi:10.1097/coc.0b013e318246b50d · Cited by 83
Moore, D. H., Donnelly, J. P., McGuire, W. P., Almadrones, L., Cella, D. F., Herzog, T. J., & Waggoner, S. E. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.02.086 · Cited by 80
Leandro-Garcia, L. J., Inglada‐Pérez, L., Pita, G., Hjerpe, E., Leskelä, S., Jara, C., Mielgo-Rubio, X., González‐Neira, A., Robledo, M., Åvall-Lundqvist, E. H., et al. (2013) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2012-101466 · Cited by 79
Neurophysiological Study of Peripheral Neuropathy after High-Dose Paclitaxel
Openshaw, H., Beamon, K., Synold, T. W., Longmate, J., Slatkin, N. E., Doroshow, J. H., Forman, S. J., Margolin, K. A., Morgan, R. J., Shibata, S., et al. (2004) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-0772-03 · Cited by 78
Paclitaxel (Taxol) induces cumulative mild neurotoxicity
van Gerven, J., Moll, J. W. B., van den Bent, M. J., Bontenbal, M., van der Burg, M. E. L., Verweij, J., & Vecht, C. J. (1994) · European Journal of Cancer · doi:10.1016/0959-8049(94)90459-6 · Cited by 77
Vincristine transcriptional regulation of efflux drug transporters in carcinoma cell lines
Huang, R. S., Murry, D. J., Kolwankar, D., Hall, S. D., & Foster, D. R. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.03.009 · Cited by 75
Leandro-Garcia, L. J., Leskelä, S., Jara, C., Gréen, H., Åvall-Lundqvist, E. H., Wheeler, H. E., Dolan, M. E., Inglada‐Pérez, L., Maliszewska, A., de Cubas, A. A., et al. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-1221 · Cited by 74
López-López, E., Gutiérrez-Camino, Á., Astigarraga, I., Navajas, A., Echebarria-Barona, A., García‐Miguel, P., de Andoín, N. G., Lobo, C., Guerra‐Merino, I., Martín‐Guerrero, I., et al. (2016) · Pharmacogenomics · doi:10.2217/pgs-2016-0001 · Cited by 73
Drug‐Induced Peripheral Neuropathy
Vilholm, O. J., Christensen, A. A., Zedan, A. H., & Itani, M. (2014) · Basic & Clinical Pharmacology & Toxicology · doi:10.1111/bcpt.12261 · Cited by 72
Effective Treatment of Oxaliplatin-Induced Cumulative Polyneuropathy With Alpha-Lipoic Acid
Gedlicka, C., Scheithauer, W., Schüll, B., & Kornek, G. V. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.99.502 · Cited by 72
Liu, J. J., Jamieson, S. M. F., Subramaniam, J., Ip, V., Jong, N. N., Mercer, J. F. B., & McKeage, M. J. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-1017-6 · Cited by 71
Hilpert, F., Stähle, A., Tomé, O., et al. (2005) · Supportive Care in Cancer · doi:10.1007/s00520-005-0782-y · Cited by 70
Johnson, C., Pankratz, V. S., Velázquez, A. I., Aakre, J. A., Loprinzi, C. L., Staff, N. P., Windebank, A. J., & Yang, P. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2014.12.041 · Cited by 68
Membrane Transporters as Determinants of the Pharmacology of Platinum Anticancer Drugs
Liu, J. J., Lu, J., & McKeage, M. J. (2012) · Current Cancer Drug Targets · doi:10.2174/156800912803251199 · Cited by 68
Durand, J.-P., Alexandre, J. R. M., Guillevin, L., & Goldwasser, F. O. (2005) · Anti-Cancer Drugs · doi:10.1097/00001813-200506000-00015 · Cited by 66
Paclitaxel‐induced neuropathic pain is age dependent and devolves on glial response
Ruiz‐Medina, J., Baulies, A., Bura, S. A., & Valverde, O. (2012) · European Journal of Pain · doi:10.1002/j.1532-2149.2012.00172.x · Cited by 65
Callizot, N., Andriambeloson, E., Glass, J. D., Revel, M., Ferro, P., Cirillo, R., Vitte, P., & Dréano, M. (2008) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-008-0689-7 · Cited by 63
Peripheral Neuropathy Caused by Paclitaxel and Docetaxel: An Evaluation and Comparison of Symptoms
Tofthagen, C., McAllister, R. D., & Visovsky, C. M. (2013) · Journal of the Advanced Practitioner in Oncology · doi:10.6004/jadpro.2013.4.4.2 · Cited by 59
Inflammasome Modulation by Chemotherapeutics in Malignant Mesothelioma
Westbom, C. M., Thompson, J. K., Leggett, A. L., MacPherson, M. B., Beuschel, S. L., Pass, H. I., Vacek, P. M., & Shukla, A. (2015) · PLoS ONE · doi:10.1371/journal.pone.0145404 · Cited by 57
Cisplatin modulates voltage gated channel currents of dorsal root ganglion neurons of rats
Tomaszewski, A., & Büsselberg, D. (2006) · NeuroToxicology · doi:10.1016/j.neuro.2006.07.005 · Cited by 55
Hertz, D. L., Owzar, K., Lessans, S., Wing, C., Jiang, C., Kelly, W. K., Patel, J. N., Halabi, S., Furukawa, Y., Wheeler, H. E., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-15-2823 · Cited by 55
Sands, S. A., Ladas, E. J., Kelly, K. M., Weiner, M. A., Lin, M., Ndao, D. H., Dave, A., Vahdat, L. T., & Bender, J. G. (2016) · Supportive Care in Cancer · doi:10.1007/s00520-016-3441-6 · Cited by 54
Liu, J. J., Kim, Y., Yan, F., Ding, Q., Ip, V., Jong, N. N., Mercer, J. F. B., & McKeage, M. J. (2012) · Biochemical Pharmacology · doi:10.1016/j.bcp.2012.10.023 · Cited by 52
Deuis, J. R., Lim, Y. L., de Sousa, S. R., Lewis, R. J., Alewood, P. F., Cabot, P. J., & Vetter, I. (2014) · Neuro-Oncology · doi:10.1093/neuonc/nou048 · Cited by 52
Self-citationProtection against oxaliplatin acute neurosensory toxicity by venlafaxine
Durand, J.-P., Brézault, C., & Goldwasser, F. (2003) · Anti-Cancer Drugs · doi:10.1097/00001813-200307000-00006 · Cited by 52
Mols, F., van de Poll-Franse, L. V., Vreugdenhil, G., Beijers, A. J. M., Kieffer, J. M., Aaronson, N. K., & Husson, O. (2016) · European Journal of Cancer · doi:10.1016/j.ejca.2016.09.020 · Cited by 52
Peripheral Neurotoxicity of Weekly Paclitaxel Chemotherapy: A Schedule or a Dose Issue?
Pace, A., Nisticò, C., Cuppone, F., Bria, E., Galiè, E., Graziano, G., Natoli, G., Sperduti, I., Jandolo, B., Calabretta, F., et al. (2007) · Clinical Breast Cancer · doi:10.3816/cbc.2007.n.010 · Cited by 51
Boora, G. K., Kulkarni, A. A., Kanwar, R., Beyerlein, P., Qin, R., Banck, M. S., Ruddy, K. J., Pleticha, J., Lynch, C. A., Behrens, R. J., et al. (2015) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2015.06.056 · Cited by 50
de Afonseca, S. O., Cruz, F. M., Cubero, D. D. I. G., Lera, A. T., Schindler, F., Okawara, M., de Souza, L. F., Rodrigues, N. P., & del Giglio, A. (2013) · Sao Paulo Medical Journal · doi:10.1590/s1516-31802013000100006 · Cited by 47
Weekly cisplatin ± glutathione in relapsed ovarian carcinoma
Colombo, N., BINI, S., Miceli, D. D., Bogliun, G., Marzorati, L., Cavaletti, G., Parmigiani, F., Venturino, P., Tedeschi, M., Frattola, L., et al. (1995) · International Journal of Gynecological Cancer · doi:10.1046/j.1525-1438.1995.05020081.x · Cited by 44
Exacerbation of oxaliplatin neurosensory toxicity following surgery
Gornet, J., Savier, É., Lokiec, F. M., Cvitkovic, E., Misset, J. L., & Goldwasser, F. (2002) · Annals of Oncology · doi:10.1093/annonc/mdf254 · Cited by 43
Wen, F., Zhou, Y., Wang, W., Hu, Q., Liu, Y. T., Zhang, P. F., Du, Z., Dai, J., & Li, Q. (2012) · Annals of Oncology · doi:10.1093/annonc/mds211 · Cited by 42
Li, D., Kim, W., Shin, D., Jung, Y.-J., Bae, H., & Kim, S. K. (2016) · Toxins · doi:10.3390/toxins8010027 · Cited by 39
Jones, D., Zhao, F., Brell, J. M., et al. (2014) · Journal of Cancer Survivorship · doi:10.1007/s11764-014-0379-x · Cited by 38
Antonacopoulou, A. G., Argyriou, A. A., Scopa, C. D., Kottorou, A. E., Kominea, A., Peroukides, S., & Kalofonos, H. P. (2010) · European Journal of Neurology · doi:10.1111/j.1468-1331.2010.02966.x · Cited by 37
Dramatic recovery of paclitaxel-disabling neurosensory toxicity following treatment with venlafaxine
Durand, J.-P., & Goldwasser, F. (2002) · Anti-Cancer Drugs · doi:10.1097/00001813-200208000-00013 · Cited by 37
Neuropeptide Y and neuron-specific enolase levels in benign and malignant pheochromocytomas
Grouzmann, E., Gicquel, C., Plouin, P., Schlumberger, M. J., Comoy, E., & Bohuon, C. (1990) · Cancer · doi:10.1002/1097-0142(19901015)66:8<1697::aid-cncr2820660808>3.0.co;2-g · Cited by 36
Dorr, R. T. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03811.x · Cited by 36
Paclitaxel-induced neuropathy: potential association of MAPT and GSK3B genotypes
Park, S. B., Kwok, J. B., Loy, C. T., Friedlander, M. L., Lin, C. S.-Y., Krishnan, A. V., Lewis, C. R., & Kiernan, M. C. (2014) · BMC Cancer · doi:10.1186/1471-2407-14-993 · Cited by 35
Lamba, J. K., Fridley, B. L., Ghosh, T. M., Yu, Q., Mehta, G., & Gupta, P. (2014) · Pharmacogenomics · doi:10.2217/pgs.14.107 · Cited by 35
Kiya, T., Kawamata, T., Namiki, A., & Yamakage, M. (2010) · Neuroscience · doi:10.1016/j.neuroscience.2010.11.046 · Cited by 31
Goswami, C. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2012.07892.x · Cited by 29
Chon, H. J., Rha, S. Y., Im, C. K., et al. (2009) · Cancer Research and Treatment · doi:10.4143/crt.2009.41.4.196 · Cited by 28
Tatsushima, Y., Egashira, N., Narishige, Y., et al. (2012) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2012.10.006 · Cited by 26
Apellániz-Ruiz, M., Tejero, H., Inglada‐Pérez, L., Sánchez, L. M. M., Gutiérrez‐Gutiérrez, G., Calvo, I., Castelo, B., Redondo, A., García-Donás, J., Romero-Laorden, N., et al. (2016) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-16-0694 · Cited by 23
Risk factors for the development of severe cisplatin neurotoxicity
Bogliun, G., Marzorati, L., Zincone, A., Crespi, V., Frattola, L., Tredici, G., & Cavaletti, G. (1997) · International Journal of Oncology · doi:10.3892/ijo.11.2.365 · Cited by 2
Cited by
Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
Zajączkowska, R., Kocot-Kępska, M., Leppert, W., Wrzosek, A., Mika, J., & Wordliczek, J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20061451 · Cited by 829
Calderón‐Ospina, C. A., & Nava‐Mesa, M. O. (2020) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.13207 · Cited by 530
Metal Drugs and the Anticancer Immune Response
Englinger, B., Pirker, C., Heffeter, P., Terenzi, A., Kowol, C. R., Keppler, B. K., & Berger, W. (2019) · Chemical Reviews · doi:10.1021/acs.chemrev.8b00396 · Cited by 355
Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment
Burgess, J., Ferdousi, M., Gosal, D., Boon, C., Matsumoto, K., Marshall, A., Mak, T., Marshall, A., Frank, B., Malik, R. A., et al. (2021) · Oncology and Therapy · doi:10.1007/s40487-021-00168-y · Cited by 306
Potential mechanisms of target-independent uptake and toxicity of antibody-drug conjugates
Mahalingaiah, P. K., Ciurlionis, R., Durbin, K. R., Yeager, R. L., Philip, B. K., Bawa, B., Mantena, S. R., Enright, B. P., Liguori, M. J., & Van Vleet, T. R. (2019) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2019.04.008 · Cited by 286
Metadata
- Authors
- Starobova, H., & Vetter, I.
- Venue
- Frontiers in Molecular Neuroscience
- Publisher
- Frontiers Media SA
- Published
- 2017-05-31
- Volume
- 10
- Pages
- 174-174
- ISSN
- 1662-5099 (ISSN-L)
- OpenAlex
- W2620036274
- Cited by
- 648
- References
- 198
- FWCI
- 18.74
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.